Top Biotechnology companies in Switzerland by EBITDA Margin
Switzerland
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
39.12%
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 2 |
34.95%
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 3 |
29.50%
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 4 |
28.28%
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 5 |
22.81%
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 6 |
19.13%
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 7 |
18.97%
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 8 |
14.71%
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 9 |
8.84%
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 10 |
8.59%
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 11 |
7.74%
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 12 |
-6.91%
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 13 |
-31.01%
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 14 |
-54.61%
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 15 |
-173.35%
|
Dec. 31, 2023 | USD 2.41 | 0.50% |
|
Switzerland |
|
| 16 |
-210.99%
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 17 |
-350.19%
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 18 |
-634.16%
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 19 |
-845.62%
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 20 |
-5,178.48%
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
Frequently Asked Questions
-
Which Biotechnology company in Switzerland has the highest EBITDA Margin ?
The Biotechnology company in Switzerland with the highest EBITDA Margin is Novartis AG (Swiss Stock Exchange: NOVN.SW) at 39.12%.
-
Which Biotechnology company in Switzerland has the lowest EBITDA Margin ?
The Biotechnology company in Switzerland with the lowest EBITDA Margin is Oculis Holding AG (NasdaqGM: OCS) at -5,178.48%.
-
What are the top 10 Biotechnology companies in Switzerland by EBITDA Margin ?
The top 10 Biotechnology companies in Switzerland by EBITDA Margin are Novartis AG, Dottikon Es Holding AG, Ypsomed Holding AG, Bachem Holding AG, Lonza Group AG, Tecan Group AG, Siegfried Holding AG, Basilea Pharmaceutica AG, Metall Zug AG and Sandoz Group AG.
-
What are the bottom 10 Biotechnology companies in Switzerland by EBITDA Margin ?
The bottom 10 Biotechnology companies in Switzerland by EBITDA Margin are Oculis Holding AG, Molecular Partners AG, Addex Therapeutics Ltd, AC Immune SA, ADC Therapeutics SA, Meyer Burger Technology AG, CRISPR Therapeutics AG, Kuros Biosciences AG, PolyPeptide Group AG and DSM-Firmenich AG.